Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)

NCT05004324 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

BIOLOGICAL: FURESTEM-AD® inj. 5.0 X 10^7 cells/1.5 mL
BIOLOGICAL: Placebo

Sponsor

Kang Stem Biotech Co., Ltd.